Blood pressure and your heart

cardiac :: Article Creator

On Call With Dr. Kumar: Benefits Of Cardiac Rehab After Heart Attack Or Stroke

On Call with Dr. Kumar: Benefits of cardiac rehab

On Call with Dr. Kumar: Benefits of cardiac rehab 03:45

NEW YORK -- After suffering major cardiac events, like heart attacks or stroke, a lot of focus goes toward medications and procedures.

But rehabilitation is also a major component of recovery.

While very important, only 8 percent of patients attend up to 36 sessions of cardiac rehab, which is considered the full dose, according to the Division for Heart Disease and Stroke Prevention.

Dr. Nidhi Kumar is On Call for CBS New York to help understand this essential part of making a full recovery.

"Cardiac rehab is a wholistic approach to recovering after having a cardiac event. It's compromised of physical activity, such as cardio and strength training, and then there's an education piece, which is so important, geared toward lifestyle changes. And finally, mindfulness based stress reduction techniques," she said. "These have been shown over and over to go a long way."

She explains cardiac rehab can help reduce hospitalizations, stroke, heart attack and heart failure, while improving quality of life.

"When people suffer a heart attack, or really any kind of cardiac event, we see that patients start to become insecure, they lack that confidence in their health," she said. "Cardiac rehab really addresses these issues. It can help people titrate their medications, so they're feeling good when they emerge back into regular physical activity. But it also helps alleviate the stress, the anxiety and the depression that also comes along with having heart disease."

Watch her full interview above for more information.

Cardiac Pacemakers Market To Expand At A 3.5% CAGR, To Attain A USD 5.9 Billion Valuation By 2031Transparency Market Research, Inc.

Transparency Market Research

The increasing prevalence of cardiovascular disease and the growing aging population worldwide are contributing to the expansion of the cardiac pacemaker market

Wilmington, Delaware, United States, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global cardiac pacemakers market is projected to grow at a CAGR of 3.5% from 2023 to 2031. As per the report published by TMR, a valuation of US$ 5.9 billion is anticipated for the market in 2031. As of 2023, the demand for cardiac pacemakers is expected to close at US$ 4.5 billion.

The growing incidence of cardiovascular conditions, such as arrhythmias, heart failure, and atrioventricular block, is a major driver for the cardiac pacemakers market. As the population ages and lifestyles change, the prevalence of these conditions continues to rise, leading to greater demand for pacemaker devices.

Growing emphasis on remote patient monitoring and telemedicine solutions in healthcare. Pacemaker devices equipped with remote monitoring capabilities allow healthcare providers to remotely track patients' cardiac health status, enabling early detection of issues and timely interventions, thus improving patient outcomes.

Get a PDF Sample Copy of the Report: https://www.Transparencymarketresearch.Com/sample/sample.Php?Flag=S&rep_id=393

The implantation of cardiac pacemakers stands out as a minimally invasive procedure, effectively mitigating the risks associated with excessive blood loss and post-operative complications. The expedited approval process for cutting-edge pacemaker technologies by regulatory bodies like the United States FDA serves as a significant catalyst, propelling the upward trajectory of the cardiac pacemaker market.

The integration of wireless connectivity and remote management capabilities in cardiac pacemakers allows both physicians and patients to conveniently access automatic test results and comprehensive diagnostics through flexible remote scheduling. This convenience is driving an increased demand for electrotherapy cardiac devices.

Story continues

Key Takeaways from the Market Study

As of 2022, the cardiac pacemakers market was valued at US$ 4.4 billion

Based on product type, the internal segment is expected to dominate the global market during the forecast period.

Cardiac Pacemakers Market: Key Trends and Opportunistic Frontiers

Growing preference for minimally invasive implantation techniques for cardiac pacemakers. These procedures reduce patient discomfort, shorten recovery times, and lower the risk of postoperative complications, driving adoption rates among patients and healthcare providers.

The rising incidence of cardiovascular diseases, such as arrhythmias, heart failure, and atrioventricular block, is a key driver for the cardiac pacemaker market.

Key trends include the development of leadless pacemakers, remote monitoring capabilities, advanced algorithms for arrhythmia detection, and longer battery life. These advancements improve patient outcomes, enhance device longevity, and increase patient convenience.

Remote patient monitoring is gaining prominence in healthcare, with pacemaker devices equipped with such capabilities witnessing growing adoption.

Cardiac Pacemakers Market – Regional Analysis

North America holds a significant share of the global cardiac pacemakers market, driven by factors such as the presence of well-established healthcare infrastructure, a high prevalence of cardiovascular diseases, and strong regulatory frameworks. The United States, in particular, accounts for a substantial portion of the market due to favorable reimbursement policies, technological advancements, and a large patient population.

The Asia-Pacific region exhibits significant growth potential in the cardiac pacemakers market, driven by factors such as a large population base, rising healthcare expenditures, and increasing prevalence of cardiovascular diseases due to lifestyle changes. Countries like China, India, and Japan are witnessing rapid market expansion, propelled by improving healthcare infrastructure, growing disposable incomes, and increasing investments by market players.

Request PDF Brochure Copy of the Report: https://www.Transparencymarketresearch.Com/sample/sample.Php?Flag=S&rep_id=393

Competitive Landscape

In the global cardiac pacemakers market companies are prioritizing the development of pacing devices equipped with remote patient monitoring functionalities. Noteworthy players are directing considerable resources toward technological advancements aimed at introducing sleeker, smarter devices. Their strategic focus encompasses bolstering device longevity, refining functionality, and ensuring compactness, all aimed at solidifying their standing in the global market landscape.

Key Product Offerings

Biotronik is a leading manufacturer of cardiovascular medical devices, including pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. The company is known for its focus on innovation, with products designed to improve patient outcomes and quality of life.

Boston Scientific Corporation offers a wide range of products for various medical specialties, including cardiac rhythm management. The company's portfolio includes pacemakers, ICDs, and CRT devices, as well as lead technologies and remote monitoring solutions.

Abbott offers a comprehensive portfolio of pacemakers, ICDs, CRT devices, and lead systems, as well as remote monitoring solutions. Abbott is known for its focus on patient-centric innovation and improving patient care.

Cardiac Pacemakers Market – Key Segments

Product Type

Technology

Dual Chambered

Single Chambered

Biventricular

Region

North America

Latin America

Europe

Asia Pacific

Middle East & Africa

Click Here To Buy Full Report! Https://www.Transparencymarketresearch.Com/checkout.Php?Rep_id=393&ltype=S

Explore TMR's Extensive Coverage in the Healthcare Domain:

Electric Tooth Polisher Market - The global electric tooth polishers market size stood at US$ 76.7 Mn in 2021 and is anticipated to expand at a CAGR of 5.5% from 2022 to 2031. Rise in demand for increasing the aesthetic appearance of teeth and rise in awareness about maintaining proper dental hygiene are expected to bolster market expansion during the forecast period.

Wireless Intraoral Camera Market - Increase in utilization of intraoral cameras in cosmetic dentistry has fueled prospects of the global wireless intraoral camera market. Adoption of advanced digital dental technologies in dentistry is creating strong growth opportunities for companies. The global market size was valued at US$ 184.0 Mn in 2021.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Nikhil SawlaniTransparency Market Research Inc.CORPORATE HEADQUARTER DOWNTOWN,1000 N. West Street,Suite 1200, Wilmington, Delaware 19801 USATel: +1-518-618-1030USA – Canada Toll Free: 866-552-3453Website: https://www.Transparencymarketresearch.Com Email: sales@transparencymarketresearch.ComFollow Us: LinkedInTwitterBlogYouTube

What Is Cardiac Amyloidosis?

Medically reviewed by Christopher Lee, MD

Cardiac amyloidosis is a condition that occurs when abnormal proteins called "amyloid" build up in your heart. These proteins can develop and grow in the heart tissue, increasing your risk for heart failure and abnormal heart rhythms. Common symptoms of this condition include fatigue, shortness of breath, and swelling in the legs. Your healthcare provider will likely prescribe you medications to treat your symptoms and help lower the risk of complications.

Types and Causes of Cardiac Amyloidosis

There are two main types of cardiac amyloidosis: light chain amyloidosis and transthyretin amyloidosis. The exact type you have will be based on the type of protein that is building up in your heart tissue. Light chain amyloidosis involves extra "light chain" proteins (which are normally made to fight infections in the body). Transthyretin amyloidosis involves a protein that normally is responsible for carrying hormones and certain vitamins in the blood.

Light Chain Amyloidosis

Light chain amyloidosis happens when certain blood cells in your body start to multiply and make too many light chain proteins. A common cause of this type of cardiac amyloidosis is having a diagnosis of certain blood cancers, like multiple myeloma.

Normally, light chain proteins play a role in your body's immune system response and help fight infections. But, when there are too many light chains in your blood, they start to accumulate in tissues where they don't belong—such as in your kidney, liver, heart, and gastrointestinal (GI) tract.

It's worth noting that light chain amyloidosis is pretty uncommon, but if you develop the condition, it can be very serious. People who develop this type are typically over the age of 40. But, the majority of light chain amyloidosis cases occur among people in their 60s or older. Generally, people assigned male at birth experience this condition more often than their female counterparts.

Transthyretin Amyloidosis

Transthyretin amyloidosis happens when the transthyretin protein (also known as prealbumin) builds up in your heart. Your liver produces the transthyretin protein and this protein normally helps carry hormones (like your thyroid hormone) in the blood. But, if you have a mutation in this type of protein, transthyretin can fold abnormally and build up throughout the body, which can cause symptoms to occur.

Symptoms

With cardiac amyloidosis, you may experience symptoms that specifically affect the heart and symptoms in other organs later on as amyloid proteins build up in your body.

Heart Symptoms

There are two main problems that amyloidosis can cause in the heart: heart failure and abnormal heart rhythms (arrhythmias).

The buildup of amyloid can affect your heart's ability to pump blood to the rest of your body. When this function is impaired, heart failure can occur and cause symptoms like:

In other cases, excess amyloid proteins can interrupt your heart's normal electrical system, which is responsible for generating your heartbeat. When this occurs, you may be at a higher risk of developing an arrhythmia. Some common symptoms of arrhythmias include:

Other Symptoms

Because many other underlying health conditions can cause heart failure and arrhythmias, it can be hard to tease out when amyloidosis is the root cause of your symptoms. However, your provider may be able to diagnose you with cardiac amyloidosis if they suspect the buildup of proteins is also affecting other parts of your body. This condition can cause one or more of the following symptoms:

Diagnosis

Diagnosing cardiac amyloidosis can be difficult since there are many causes of heart failure and arrhythmias. Cardiologists (or, doctors who specialize in the heart) are now recognizing that cardiac amyloidosis is actually much more common than previously thought. If you have any symptoms of this condition, it's important to schedule an appointment with your healthcare provider.

At your appointment, your healthcare provider will ask about your medical history and perform a physical exam. However, they will likely order several other tests to confirm a diagnosis and understand the cause of your symptoms. These exams may include:

Blood test: Checks the levels of heart biomarkers, kidney function, and electrolytes

Urine test: Looks for protein buildup in the urine, such as albumin and light chains

Heart imaging scan: Creates detailed images of your heart's structure via an echocardiogram (heart ultrasound), heart magnetic resonance imaging (MRI), and nuclear imaging such as pyrophosphate scan

Heart biopsy: Removes and analyzes a portion of your heart tissue to determine if amyloid proteins are present

Bone marrow biopsy: Takes a sample of your bone marrow to look for blood cells that have multiplied or are making too many light chain proteins

Genetic test: Assesses whether you have mutations in the transthyretin gene

Treatment

If you receive a diagnosis for cardiac amyloidosis, the goals of treatment are to reduce your symptoms, treat the underlying cause of your symptoms, and improve your quality of life. Your exact treatment plan will depend on the severity of your condition.

Treatment for Reducing Symptoms

If your condition is causing heart failure or arrhythmias, your provider will likely recommend treatment to reduce the symptoms of each.

Some treatments for heart failure include:

Taking diuretics (water pills) to manage fluid buildup

Limiting your salt intake

Using medications like ACE inhibitors

Getting a heart transplant, in very severe cases

To treat arrhythmias, your provider may recommend:

Using antiarrhythmic drugs

Getting an ablation procedure to reset the heart's rhythm

Inserting a pacemaker into your heart

Taking blood thinners to help lower the risk of stroke

Treatment for Light Chain Amyloidosis

To treat light chain amyloidosis specifically, your provider may recommend therapies that target the blood cells that are creating too many light chain proteins. These therapies include chemotherapy and a stem cell transplant. Chemotherapy kills off the abnormal cells that are making too much light chain protein. Meanwhile, a stem cell transplant occurs after chemotherapy removes abnormal cells and injects new stem cells as a replacement.

Treatment for Transthyretin Amyloidosis

Until recently, there were no direct treatments for transthyretin amyloidosis. Medications to help manage symptoms were the only option available. But in 2019, the U.S. Food and Drug Administration (FDA) approved Vyndamax (tafamidis) which became the first medication to treat transthyretin amyloidosis.

While Vyndamax won't reverse the abnormal proteins that have already built up in your heart, this medication can prevent more amyloid proteins from accumulating in your heart's tissue. In clinical trials, people taking this medication experienced higher survival rates when compared to people with cardiac amyloidosis who were not taking this medication.

How To Prevent Cardiac Amyloidosis

There aren't any surefire ways to prevent cardiac amyloidosis. However, identifying the symptoms and receiving an early diagnosis can help you get treatment sooner and improve your quality of life. It's a good idea to be proactive if you start experiencing symptoms and see your healthcare provider for proper testing.

Related Conditions

Cardiac amyloidosis has several related conditions. The following blood disorders may increase your risk of developing cardiac amyloidosis:

It's also worth noting that having a diagnosis for cardiac amyloidosis can also increase your risk of experiencing other health conditions that may occur due to a buildup of amyloid:

Carpal tunnel syndrome

Lumbar spinal stenosis (the narrowing of your spinal cord in the lower back, causing back pain)

Joint problems that require a joint replacement (such as shoulder, hip, or knee replacement)

Living with Cardiac Amyloidosis

It can be worrisome or overwhelming to receive a diagnosis for cardiac amyloidosis. However, staying in contact with your healthcare team (which may include your primary care provider and cardiologist) can help you get the support and care you need. At your check-up appointments, it's good practice to let your care team know if you notice any change in your symptoms.

Healthcare providers also recommend keeping track of your weight if you have this condition. That's because cardiac amyloidosis can often cause fluid buildup. If you notice that your weight has increased more than two or three pounds in just one day, it could be a sign of extra fluid. Letting your healthcare provider know about your weight changes can help them adjust your treatment plan or prescribe diuretics to help rid your body of excess water.

Cardiac amyloidosis can affect your everyday life, making it hard to perform your daily activities and taking a toll on your emotional well-being. Keeping in touch with your providers is just one way to take care of your health. But, asking your loved ones for support, joining a support group with other people living with this condition, or talking to a mental health professional (such as a psychiatrist or psychologist) can help you live well with the condition and get the care you need.

For more Health.Com news, make sure to sign up for our newsletter!

Read the original article on Health.Com.

View comments

Search This Blog

Hypertension